N22000
yw31c12.s1 Morton Fetal Cochlea Homo sapiens cDNA clone IMAGE:253846 3' similar to gb:M11717_rna1 HEAT SHOCK 70 KD PROTEIN 1 (HUMAN), mRNA sequence.
456
mRNA
Homo sapiens
DL031014
JP 2005512499-A/22000: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
545
DNA
synthetic construct
HV878541
JP 2010507387-A/21952: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
DD548603
JP 2004508801-A/22000: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
DL903744
JP 2014205669-A/22000: Method of constructing and screening libraries of peptide structures.
25
PRT
synthetic construct
PA337648
JP 2021522188-A/22000: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
FU796481
JP 2009528046-A/21998: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
HW187028
JP 2013102767-A/21952: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DM796458
JP 2014068652-A/22000: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
MC774110
JP 2018525446-A/22000: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
41
PRT
synthetic construct
DL612602
JP 2011092200-A/22000: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
LF829156
JP 2016528161-A/21989: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
HW857224
JP 2015051004-A/21952: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
LV567822
JP 2017029159-A/22000: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
MC163844
JP 2019500349-A/22000: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
PA392723
JP 2021533803-A/21806: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
PA526484
JP 2022502046-A/9266: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
OG751519
JP 2021120380-A/22000: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
LF681221
JP 2016521556-A/22000: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
DJ525800
JP 2010517930-A/22000: Method of constructing and screening libraries of peptide structures.
25
PRT
synthetic construct
HZ526781
JP 2016501039-A/22000: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
MC550500
JP 2019525738-A/22000: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
107
PRT
synthetic construct
DD802270
JP 2008525033-A/22000: Group B Streptococcus.
247
PRT
Streptococcus agalactiae
PD709914
JP 2021530475-A/21996: De novo Design of Protein Switches.
56
PRT
synthetic construct
DJ151380
JP 2007228956-A/21998: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
MD754242
JP 2019507579-A/22000: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
LX119616
JP 2017506877-A/21998: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
MD268133
JP 2020517247-A/22000: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
DM758694
JP 2014079248-A/22000: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
MB763216
JP 2018535655-A/27113: ASGR INHIBITORS.
7
PRT
synthetic construct